Bacteria in gut 'play role in irritable bowel syndrome'

   May 27, 6:42 pm

Washington, May 27 (ANI): A new study has definitively linked an overgrowth of bacteria in the gut to the Irritable Bowel Syndrome (IBS).

This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated number of 30 million people in the United States.

Earlier studies have indicated that bacteria play a role in the disease, including breath tests detecting methane - a byproduct of bacterial fermentation in the gut. This study was the first to make the link using bacterial cultures.

Cedars-Sinai physician examined samples of patients' small bowel cultures to confirm the presence of small intestinal bacterial overgrowth - or SIBO - in more than 320 subjects.

In patients with IBS, more than a third were also diagnosed with small intestine bacterial overgrowth, in comparison to fewer than 10 percent of those without the disorder.

Out of those with diarrhea-predominant IBS, 60 percent also had bacterial overgrowth.

"While we found compelling evidence in the past that bacterial overgrowth is a contributing cause of IBS, making this link through bacterial cultures is the gold standard of diagnosis," said Mark Pimentel, MD, director of the Cedars-Sinai GI Motility Program and an author of the study.

"This clear evidence of the role bacteria play in the disease underscores our clinical trial findings, which show that antibiotics are a successful treatment for IBS," he said.

Patients with IBS suffer symptoms that can include painful bloating, constipation, diarrhea or an alternating pattern of both.

Many of these patients try to avoid social interactions because they are embarrassed by their symptoms.

Pimentel has led clinical trials that have shown Rifaximin, a targeted antibiotic absorbed only in the gut, is an effective treatment for patients with IBS.

"In the past, treatments for IBS have always focused on trying to alleviate the symptoms," said Pimentel, who first bucked standard medical thought more than a decade ago when he suggested bacteria played a major role in the disease.

"Patients who take Rifaximin experience relief of their symptoms even after they stop taking the medication. This new study confirms what our findings with the antibiotic and our previous studies always led us to believe: Bacteria are key contributors to the cause of IBS ," he said.

This study has been published in Digestive Diseases and Sciences. (ANI)

Alcohol consumption, smoking, obesity may help predict Alzheimer Jul 29, 4:46 pm
Washington DC, July 29 (ANI): A new study suggests that alcohol consumption, smoking, obesity and diabetes are associated with smaller regional brain volumes that may be early indicators of Alzheimer's disease and dementia.
Full Story
Genes' role in disease revealed by mouse study Jul 29, 4:41 pm
Washington DC, July 29 (ANI): Major European mouse study has revealed the role of genes in the disease.
Full Story
Apollo Munich pledges against dengue, launches cover policy at Rs 1.22/day Jul 29, 1:52 pm
New Delhi, July 29 (ANI): With the monsoon spreading across the country, India's leading standalone health insurance company 'Apollo Munich Health Insurance' has introduced a 'Dengue Care' policy at an affordable one-time premium of Rs. 444.
Full Story
Skipping breakfast could be 'dangerously harmful' to diabetics' health Jul 29, 1:20 pm
Washington DC, July 29 (ANI): Diabetes patients who tend to skip their breakfast, keeping their bellies empty till noon, face risk of dangerous blood sugar spikes, claims a new study.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY